Back to Markets
RORoivant Sciences Ltd

Roivant Sciences Ltd

ROIVNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$29.99

+0.1100 (+0.37%)

As of 05/29/26 EDT · USD

Compare
Low: $10.71Current: $29.99High: $32.79

Key Statistics

Open

$30.30

Day High

$30.42

Day Low

$29.65

Prev. Close

$29.88

VolumeShares traded today.

6.85M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$21.57B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-66.03

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$32.79

52W LowLowest price over the past 52 weeks.

$10.71

50D MAAverage closing price over the last 50 trading days.

$28.58

200D MAAverage closing price over the last 200 trading days.

$22.32

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-2.9%

1M

+9.0%

6M

+43.8%

YTD

+36.8%

1Y

+172.9%

About

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

roivant.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ROIV

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.